Mylan Boosts Price Assistance for EpiPen Amid Backlash

Mylan responded to backlash over the price of its EpiPen by promising to reduce the costs that some patients pay, though stopped short of saying it would cut prices.

from WSJ.com: US Business http://ift.tt/2bl9yzi
via IFTTT